InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Higuchi John W.. Director active across 1 company, notably Lipocine Inc.. In total, 2 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €288k. Activity tracked since 6 April 2026. The latest transaction was disclosed on 7 April 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations